Brainsway Ltd.
Develops noninvasive Deep TMS therapy for depression, OCD, and smoking cessation.
BWAY | TA
Overview
Corporate Details
- ISIN(s):
- IL0011007189
- LEI:
- Country:
- Israel
- Address:
- 16 Hartum St, 9777516 Har Hotzvim, Jerusalem
- Website:
- https://www.brainsway.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
BrainsWay Ltd. is a global medical technology company specializing in the development and commercialization of advanced noninvasive neurostimulation treatments for mental health disorders. The company's core technology is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform, which utilizes a patented H-coil to safely stimulate deeper and broader regions of the brain. BrainsWay's systems are FDA-cleared for treating a range of conditions, including Major Depressive Disorder (MDD), Anxious Depression, Obsessive-Compulsive Disorder (OCD), and as an aid for short-term smoking cessation in adults. The company holds the first FDA clearance for a noninvasive medical device for OCD and the first in the addiction space for any TMS device.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-27 14:30 |
Foreign Filer Report
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Menta…
|
English | 82.4 KB | ||
| 2025-10-27 14:30 |
Foreign Filer Report
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Menta…
|
English | 36.7 KB | ||
| 2025-10-14 15:00 |
Foreign Filer Report
Immediate Report
|
English | 176.6 KB | ||
| 2025-10-14 15:00 |
Foreign Filer Report
Immediate Report
|
English | 36.4 KB | ||
| 2025-10-01 01:01 |
Foreign Filer Report
Report of Periodic or Interim Report
|
English | 1.5 MB | ||
| 2025-10-01 01:01 |
Report Publication Announcement
Report of Periodic or Interim Report
|
English | 36.8 KB | ||
| 2025-09-16 17:29 |
Foreign Filer Report
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Inva…
|
English | 122.4 KB | ||
| 2025-09-16 17:29 |
Foreign Filer Report
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Inva…
|
English | 36.7 KB | ||
| 2025-09-12 01:01 |
Foreign Filer Report
Immediate Report
|
English | 122.8 KB | ||
| 2025-09-12 01:01 |
Post-Annual General Meeting Information
Immediate Report
|
English | 36.4 KB | ||
| 2025-08-21 16:30 |
Foreign Filer Report
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic…
|
English | 1.3 MB | ||
| 2025-08-21 16:30 |
Foreign Filer Report
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic…
|
English | 36.5 KB | ||
| 2025-08-20 16:30 |
Foreign Filer Report
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
|
English | 192.4 KB | ||
| 2025-08-20 16:30 |
Foreign Filer Report
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
|
English | 36.5 KB | ||
| 2025-08-13 16:30 |
Investor Presentation
Corporate Presentation
|
English | 6.8 MB |
Automate Your Workflow. Get a real-time feed of all Brainsway Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Brainsway Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Brainsway Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
